Phase
Startup
Prolevi Bio
Prolevi is an international start-up with a long-term aim to target metabolic disorders. Women’s health is largely underfunded, and Prolevi initially addresses one of the biggest challenges, hypothyroidism (90% females) which is an area with large unmet need as many patients do not respond to current therapy. The company is developing personalized therapy, by biomimicking the natural release cycles for the active thyroid hormone in non-respondents.
Sahil Gupta started his journey with biotech studies in India, followed by a Master’s program at LMU in Munich, PhD at Goethe University in Frankfurt, and a postdoc fellowship in The Netherlands. Sahil contacted a founding investor with ideas in the autoimmunology and cancer space through Nested Bio. These discussions led to Prolevi Bio AB foundation in December 2021 and introduction of other co-founders.
Did you know?
In the world population, around 5% – of which the majority are women – are diagnosed with hypothyroidism. However, one in five patients does not respond to current treatment. Prolevi’s aim is to provide treatment to hypothyroid patients who are non-respondent, about 150 million worldwide.
Medicines for acute systemic inflammatory diseases
Cancer immunotherapies based in cell reprogramming
Cell factories for dairy processing
Automated microscopy image acquisition and analysis
Implants of magnesium alloys
Developing future targeted immunotherapies in cancer
Digital service for patients
Medical device that reduces pain during vein operation
Cloud-based solutions for genomics data
A reusable, user-friendly, and sustainable pregnancy test
Digital assistive device for post-surgical rehabilitation
Develops the first effective treatment for hypothyroidism
Builds gene therapy viral vectors
Early detection of pancreatic cancer
Bio-based vegan coating for fruits and vegetables
Equipment that improves the function of cultivated cells
Medtech solution for preventing pressure ulcers
Effective treatments for brain tumors
A new suturing choice for abdominal wall closure
Converting waste flows into valuable raw materials
Innovative systemic anti-inflammatory treatments
Safer medical needles for prostate biopsy
